These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 816003)

  • 1. Specific acquired resistance and activity of migration inhibition factor (MIF) in spleens of mice with chronic tuberculosis.
    Kvapilová M; Trnka L; Svejcar J; Pekárek J
    Scand J Respir Dis; 1975; 56(6):305-11. PubMed ID: 816003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity in natural and experimental infections caused by Mycobacterium tuberculosis and Mycobacterium kansasii.
    Kubín M
    Czech Med; 1980; 3(2):138-43. PubMed ID: 6774866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression and experimental tuberculosis. II. The effects of immunosuppressive agents and antilymphocyte serum on the organ dissemination of mycobacteria and on the development of specific delayed hypersensitivity.
    Müllerova M; Pekárek J; Nouza K; Svejcar J; Trnka L; Matousek V
    Biomedicine; 1974 Nov; 20(6):390-7. PubMed ID: 4218118
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between immunopotency tests and specific active or passive acquired resistance against Mycobacterium tuberculosis in mice induced with three different preparations of BCG pasteur vaccine.
    Brandely M; Hurtrel B; Lagrange PH
    Clin Exp Immunol; 1983 Oct; 54(1):143-50. PubMed ID: 6413106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects.
    James SL; DeBlois LA
    J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cell-mediated immunity and immediate hypersensitivity in animal model.
    Wolf R; Livni E; Joshua H
    Ann Allergy; 1984 Apr; 52(4):300-2. PubMed ID: 6370046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia virus-induced immunosuppression. 8. Rapid depression of in vitro leukocyte migration after infection of mice with Friend leukemia virus.
    Friedman H; Ceglowski WS
    J Immunol; 1971 Dec; 107(6):1673-81. PubMed ID: 5000989
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of bilirubin on an in vitro correlate of cell-mediated immunity--the migration inhibition test.
    Svejcar J; Miler I; Pekárek J
    J Clin Lab Immunol; 1984 Mar; 13(3):145-9. PubMed ID: 6371239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
    Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
    Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    Orme IM; Collins FM
    J Immunol; 1983 Sep; 131(3):1452-4. PubMed ID: 6411817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mortality of cadmium-intoxicated mice infected with the BCG strain of Mycobacterium bovis.
    Bozelka BE; Burkholder PM
    J Reticuloendothel Soc; 1979 Sep; 26(3):229-37. PubMed ID: 387955
    [No Abstract]   [Full Text] [Related]  

  • 14. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
    Doherty TM; Sher A
    J Immunol; 1997 May; 158(10):4822-31. PubMed ID: 9144497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection.
    Orme IM
    J Immunol; 1988 May; 140(10):3589-93. PubMed ID: 3129497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
    Cooper AM; Roberts AD; Rhoades ER; Callahan JE; Getzy DM; Orme IM
    Immunology; 1995 Mar; 84(3):423-32. PubMed ID: 7751026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological mechanisms controlling mycobacterial infections.
    Lagrange PH; Hurtrel B; Brandely M; Thickstun PM
    Bull Eur Physiopathol Respir; 1983; 19(2):163-72. PubMed ID: 6409192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressive drugs on an in vito correlate of cell-mediated immunity. The migration inhibition test.
    Pekárek J; Svejcar J; Nouza K; Johanovsky J
    Immunology; 1976 Nov; 31(5):773-9. PubMed ID: 791852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.